Journal of Bone and Mineral Metabolism

Papers
(The H4-Index of Journal of Bone and Mineral Metabolism is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Discovery of the RANKL/RANK/OPG system103
RANKL as the master regulator of osteoclast differentiation90
Sclerostin: from bench to bedside52
Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational study31
Regulation of T cell-associated tissues and T cell activation by RANKL-RANK-OPG31
Novel microbiota-related gene set enrichment analysis identified osteoporosis associated gut microbiota from autoimmune diseases30
Teriparatide and exercise improve bone, skeletal muscle, and fat parameters in ovariectomized and tail-suspended rats26
Selenium-modified calcium phosphate cement can accelerate bone regeneration of osteoporotic bone defect25
Blood lipid levels in patients with osteopenia and osteoporosis:a systematic review and meta-analysis22
Impact of high-load resistance training on bone mineral density in osteoporosis and osteopenia: a meta-analysis21
Bone fracture healing: perspectives according to molecular basis20
Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw20
Oral risk factors associated with medication-related osteonecrosis of the jaw in patients with cancer19
Performance of the Nottingham Hip Fracture Score and Clinical Frailty Scale as predictors of short and long-term outcomes: a dual-centre 3-year observational study of hip fracture patients18
Fecal microbiota transplantation as a promising treatment option for osteoporosis18
Relationship between serum vitamin D and hip fracture in the elderly: a systematic review and meta-analysis17
Role of irisin in effects of chronic exercise on muscle and bone in ovariectomized mice17
Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF2317
LncPVT1 promotes cartilage degradation in diabetic OA mice by downregulating miR-146a and activating TGF-β/SMAD4 signaling17
0.085639953613281